Literature DB >> 16256273

Evidence of a role for descending serotonergic facilitation in a rat model of cancer-induced bone pain.

Tansy Donovan-Rodriguez1, Catherine E Urch, Anthony H Dickenson.   

Abstract

Descending modulation of spinal processing plays an important role in chronic pain states. Monoamine pathways comprise a major component of descending controls from the brainstem to the spinal cord. Recent emphasis has been on facilitatory actions mediated by the 5-HT3 receptor. We investigated the effects of spinally administered ondansetron, a selective 5-HT3 receptor antagonist, on electrical- and natural-evoked dorsal horn (DH) neuronal responses in a rat model of cancer-induced bone pain (CIBP). Injection of MRMT-1 cells into the tibiae of Sprague-Dawley rats was used to model CIBP, whilst sham-operated rats were injected with the cell medium alone. Behavioural testing at regular intervals monitored the development of mechanical allodynia, cold allodynia, and ambulatory-evoked pain. In vivo electrophysiology experiments were carried out 15-17 days after surgery, when there were significant behavioural and neuronal alterations in the cancer animals. Spinally administered ondansetron (10, 50, and 100 microg) had no effect on electrical-evoked neuronal responses, but significantly reduced mechanical- and thermal-evoked responses in both the groups of animals. Furthermore, the effects of ondansetron were significantly greater in cancer animals compared to shams. These results therefore suggest a role for descending serotonergic facilitation in CIBP.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16256273     DOI: 10.1016/j.neulet.2005.09.073

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  21 in total

1.  Cancer pain physiology.

Authors:  Sarah Falk; Kirsty Bannister; Anthony H Dickenson
Journal:  Br J Pain       Date:  2014-11

2.  Differential modulation of neurons in the rostral ventromedial medulla by neurokinin-1 receptors.

Authors:  Thaddeus S Brink; Cholawat Pacharinsak; Sergey G Khasabov; Alvin J Beitz; Donald A Simone
Journal:  J Neurophysiol       Date:  2011-10-26       Impact factor: 2.714

3.  Loss of neurons in rostral ventromedial medulla that express neurokinin-1 receptors decreases the development of hyperalgesia.

Authors:  S G Khasabov; D A Simone
Journal:  Neuroscience       Date:  2013-07-03       Impact factor: 3.590

4.  5-hydroxytryptamine type 3 receptor modulates opioid-induced hyperalgesia and tolerance in mice.

Authors:  De-Yong Liang; XiangQi Li; J David Clark
Journal:  Anesthesiology       Date:  2011-05       Impact factor: 7.892

5.  Downregulation of PI3Kcb utilizing adenovirus-mediated transfer of siRNA attenuates bone cancer pain.

Authors:  Huan-Jun Huang; Mei Zhang
Journal:  Int J Clin Exp Pathol       Date:  2014-10-15

6.  Descending serotonergic facilitation and the antinociceptive effects of pregabalin in a rat model of osteoarthritic pain.

Authors:  Wahida Rahman; Claudia S Bauer; Kirsty Bannister; Jean-Laurent Vonsy; Annette C Dolphin; Anthony H Dickenson
Journal:  Mol Pain       Date:  2009-08-07       Impact factor: 3.395

7.  Behavioral, medical imaging and histopathological features of a new rat model of bone cancer pain.

Authors:  Louis Doré-Savard; Valérie Otis; Karine Belleville; Myriam Lemire; Mélanie Archambault; Luc Tremblay; Jean-François Beaudoin; Nicolas Beaudet; Roger Lecomte; Martin Lepage; Louis Gendron; Philippe Sarret
Journal:  PLoS One       Date:  2010-10-29       Impact factor: 3.240

Review 8.  Animal models of cancer pain.

Authors:  Cholawat Pacharinsak; Alvin Beitz
Journal:  Comp Med       Date:  2008-06       Impact factor: 0.982

Review 9.  Preclinical and early clinical investigations related to monoaminergic pain modulation.

Authors:  Kirsty Bannister; Lucy A Bee; Anthony H Dickenson
Journal:  Neurotherapeutics       Date:  2009-10       Impact factor: 7.620

10.  Changes in response properties of rostral ventromedial medulla neurons during prolonged inflammation: modulation by neurokinin-1 receptors.

Authors:  S G Khasabov; T S Brink; M Schupp; J Noack; D A Simone
Journal:  Neuroscience       Date:  2012-08-20       Impact factor: 3.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.